The European Patent Office (EPO) has published patent application EP2026030201A2, titled 'Vaccine antigens and use thereof.' This publication, dated March 18, 2026, relates to specific classifications within biotechnology and protein chemistry (C07K 14/005 and C12N 15/86). The application is designated for numerous European states.

This is a patent publication, not a regulatory rule or guidance. It does not impose new compliance obligations or deadlines on regulated entities. Companies operating in the biotechnology and pharmaceutical sectors may wish to review this publication for potential intellectual property insights or competitive intelligence. No immediate action is required from compliance officers.